Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 347-349

  Korman, Howard J ^b   Peabody, James O ^a   Cerny, Joseph C ^b   Farah, Riad N ^b   Yao, Jiping ^b   Raz, Avraham ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

Autocrine motility factor; Biological markers; Bladder neoplasms

Indexed keywords

AUTOCRINE MOTILITY FACTOR; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; URINE LEVEL;

ADULT; AGED; BLADDER; BLADDER NEOPLASMS; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; NEOPLASM INVASIVENESS; RECEPTORS, CYTOKINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL;

EID: 0029655913     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66658-8     Document Type: Article

References (11)

1. Ro, J. Y., Staerkel, G. A. and Ayala, A. G.: Cytologie and histologie features of superficial bladder cancer. Urol. Clin. North Am., 19: 435, 1992.
2. Heney, N. M.: Natural history of superficial bladder cancer. Urol. Clin. North Am., 19: 429, 1992.
3. Badalament, R. A., Ortolano, V. and Burgers, J. K.: Recurrent or aggressive bladder cancer: indications for adjuvant intravesical therapy. Urol. Clin. North Am., 19: 485, 1992.
4. Fradet, Y.: Markers of prognosis in superficial bladder cancer. Semin. Urol., 10: 28, 1992.
5. Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K. and Schiffman, E.: Tumor cell automne motility factor. Proc. Natl. Acad. Sci. U.S.A., 83: 3302, 1986.
6. Watanabe, H., Carmi, P., Hogan, V., Raz, T., Siletti, S., Nabi, I. R. and Raz, A.: Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J. Biol. Chem., 266: 13442, 1991.
7. Otto, T., Birchmeier, W., Schmidt, U., Hinke, A., Schipper, J., Rubben, H. and Raz, A.: Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res., 54: 3120, 1994.
8. Nakamori, S., Watanabe, H., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Kabuto, T. and Raz, A.: Expression of autocrine motility factor receptor in colorectal cancer as a predictor of disease recurrence. Cancer, 74: 1855, 1994.
9. Fleiss, J.: Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley and Sons, pp. 147-149, 1981.
10. Heney, N. M., Ahmed, S. and Flanagan, M. J.: Superficial bladder cancer: progression and recurrence. J. Urol., 128: 31, 1983.
11. Guirguis, R., Schiffman, E., Liu, B., Birkbeck, D., Engel, J. and Liotta, L.: Detection of autocrine motility factor in urine as a marker of bladder cancer. J. Natl. Cancer Inst., 80: 1203, 1988.